Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$2.83B
+109.8% from 2023
Prescriptions
109K
$25,882.18 per claim
Patients
14K
4,416 prescribers
Total spending, 2024
$2.83B
$203,289.90 per patient
Medicare prescription drug plans paid $2.83B for Vyndamax in 2024, for 109,373 prescriptions and refills to 13,925 patients (up 109.8% from 2023). The average cost per claim was $25,882.18.
New York had the highest Medicare cost for Vyndamax in 2024: $334.4M for 11,451 claims, followed by California ($243.2M).
Sarah Cuddy, cardiology in Boston, MA, had the highest Medicare cost for Vyndamax in 2024: 1,675 claims costing $39.5M.
Vyndamax is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Pfizer US Pharm.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Sarah Cuddy Boston, MA | Cardiology | 1,675 | 189 | $39.5M |
| Maureen C Geary New York, NY | Nurse Practitioner | 1,057 | 187 | $37.1M |
| Brian M Drachman |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 2,100 | 34,843 | 5,087 | $845.0M |
| 2023 | 2,926 | 52,367 | 7,586 | $1.35B |
| 2024 | 4,416 | 109,373 | 13,925 | $2.83B |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Cardiology |
| 1,013 |
| 133 |
| $28.2M |
| Margaret O Cuomo New York, NY | Nurse Practitioner | 892 | 137 | $27.2M |
| Prem Soman Pittsburgh, PA | Cardiology | 964 | 111 | $22.5M |
| Zubair I Shah Kansas City, KS | Advanced Heart Failure and Transplant Cardiology | 958 | 110 | $21.1M |
| Kunal N Bhatt Atlanta, GA | Advanced Heart Failure and Transplant Cardiology | 755 | 92 | $18.8M |
| Mazen A Hanna Cleveland, OH | Advanced Heart Failure and Transplant Cardiology | 740 | 89 | $18.2M |
| Janice Pieretti Philadelphia, PA | Advanced Heart Failure and Transplant Cardiology | 572 | 89 | $16.8M |
| Josef Stehlik Salt Lake City, UT | Cardiology | 725 | 76 | $16.7M |
| Sabeena Arora Hartford, CT | Cardiology | 537 | 94 | $16.5M |
| Ronald M Witteles Stanford, CA | Cardiology | 621 | 64 | $14.6M |
| Ahmad M Masri Portland, OR | Cardiology | 548 | 70 | $14.2M |
| Brett W Sperry Kansas City, MO | Advanced Heart Failure and Transplant Cardiology | 611 | 71 | $14.1M |
| Hanna K Gaggin Boston, MA | Cardiology | 581 | 71 | $13.5M |
| Edward J Miller New Haven, CT | Cardiology | 518 | 68 | $13.4M |
| Rebecca R Hung Nashville, TN | Cardiology | 531 | 63 | $13.2M |
| Joban Vaishnav Baltimore, MD | Cardiology | 391 | 65 | $12.7M |
| Elsy V Navas Naples, FL | Advanced Heart Failure and Transplant Cardiology | 429 | 61 | $11.9M |
| Kaylee M Baker Philadelphia, PA | Nurse Practitioner | 432 | 60 | $11.8M |
| David L Stern Great Neck, NY | Cardiology | 404 | 59 | $11.6M |
| Richard K Cheng Seattle, WA | Advanced Heart Failure and Transplant Cardiology | 401 | 47 | $11.3M |
| Cesia Maria Gallegos Kattan New Haven, CT | Cardiology | 401 | 53 | $11.2M |
| Omar K Siddiqi Boston, MA | Cardiology | 462 | 48 | $11.1M |
| Brendan J Carry Danville, PA | Internal Medicine | 493 | 55 | $10.7M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Pfizer US Pharm PFE | 109,373 | $2.83B |